Skip to content
PAD
Pounce System
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
PAD
Pounce System
DETOUR System
DETOUR System Reimbursement
DETOUR Professional Education
For PAD Patients
Find a Doctor
AAA
AAA
ALTO
AFX2
EVAR for Women
EVAR Portfolio Resources
Clinical Evidence
Procedural Training
IFU’s
About Us
About Us
News
The Team
Careers
Internal Applicant Portal
External Applicant Portal
Investigator Initiated
Research
Contact Us
Search
Back to News
January 25, 2017
Endologix Announces Reinstatement of CE Mark for AFX® and AFX®2 Endovascular AAA System
Prev
Previous
Endologix Resumes Shipments of All Sizes of AFX®2 Endovascular AAA Systems Appoints Laura Nagel as Vice President, Global Quality
Next
Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium
Next
